- Home
- ATHA vs GRYP Comparison
ATHA vs GRYP Comparison
Compare ATHA & GRYP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATHA
- GRYP
- Stock Information
- Founded
- ATHA 2011
- GRYP 2010
- Country
- ATHA United States
- GRYP United States
- Employees
- ATHA N/A
- GRYP N/A
- Industry
- ATHA Medicinal Chemicals and Botanical Products
- GRYP
- Sector
- ATHA Health Care
- GRYP
- Exchange
- ATHA Nasdaq
- GRYP Nasdaq
- Market Cap
- ATHA 22.3M
- GRYP 18.0M
- IPO Year
- ATHA 2020
- GRYP N/A
- Fundamental
- Price
- ATHA $0.54
- GRYP $0.38
- Analyst Decision
- ATHA Buy
- GRYP Hold
- Analyst Count
- ATHA 4
- GRYP 1
- Target Price
- ATHA $11.25
- GRYP N/A
- AVG Volume (30 Days)
- ATHA 325.4K
- GRYP 976.1K
- Earning Date
- ATHA 11-07-2024
- GRYP 11-13-2024
- Dividend Yield
- ATHA N/A
- GRYP N/A
- EPS Growth
- ATHA N/A
- GRYP N/A
- EPS
- ATHA N/A
- GRYP N/A
- Revenue
- ATHA N/A
- GRYP $22,783,000.00
- Revenue This Year
- ATHA N/A
- GRYP N/A
- Revenue Next Year
- ATHA N/A
- GRYP N/A
- P/E Ratio
- ATHA N/A
- GRYP N/A
- Revenue Growth
- ATHA N/A
- GRYP 14.06
- 52 Week Low
- ATHA $0.41
- GRYP $0.38
- 52 Week High
- ATHA $4.30
- GRYP $10.30
- Technical
- Relative Strength Index (RSI)
- ATHA 36.91
- GRYP 27.53
- Support Level
- ATHA $0.56
- GRYP $0.52
- Resistance Level
- ATHA $0.61
- GRYP $0.73
- Average True Range (ATR)
- ATHA 0.04
- GRYP 0.08
- MACD
- ATHA -0.01
- GRYP -0.03
- Stochastic Oscillator
- ATHA 8.45
- GRYP 0.76
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) a subcutaneously administered, small molecule positive modulator of the HGF/MET system for CNS disorders, ATH-1020 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system. ATH-1105 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system, and several other compounds in preclinical discovery and development for neurodegenerative diseases, including ATH-1018 and ATH-1019.
About GRYP Gryphon Digital Mining Inc Common Stock
Gryphon Digital Mining Inc is a Bitcoin mining company. Gryphon's mission is to create the world's leading net carbon-neutral Bitcoin miner. The company will operate a digital asset, mining operation using specialized computers equipped with application-specific integrated circuit (ASIC) chips to solve complex cryptographic algorithms in support of the Bitcoin blockchain in exchange for cryptocurrency rewards (primarily Bitcoin).